Chemical compounds: Artemisinin (PubChem CID: 68827); Cannabidiol (PubChem CID: 26346); Cannabinol (PubChem CID: 2543); Dehydrocostuslactone (PubChem CID: 73174); Marrubiin (PubChem CID: 73401); Thapsigarin (PubChem CID:446378); Δ9-tetrahydrocannabinol (PubChem CID: 2977)
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
Version of Record online: 12 MAY 2014
© 2014 Royal Pharmaceutical Society
Journal of Pharmacy and Pharmacology
Volume 66, Issue 11, pages 1505–1525, November 2014
How to Cite
Beukes, N., Levendal, R.-A. and Frost, C. L. (2014), Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders. Journal of Pharmacy and Pharmacology, 66: 1505–1525. doi: 10.1111/jphp.12267
- Issue online: 16 OCT 2014
- Version of Record online: 12 MAY 2014
- Manuscript Accepted: 16 MAR 2014
- Manuscript Received: 25 NOV 2013
- signalling pathways;
- unfolded protein response
The majority of research performed on cellular stress and apoptosis focuses on mitochondrial dysfunction; however, the importance of the endoplasmic reticulum dysfunction and the link to metabolic diseases has gained a substantial interest. This review focuses on the potential of terpenoids to influence endoplasmic reticulum stress and the possible role terpenoids play as the treatment of metabolic diseases.
Metabolic diseases develop as a result of a cascade of cellular pathways. In most cases, cells are able to compensate for the disruption of the cellular homeostasis although the initiation of response pathways; however, chronic stress initiates apoptotic pathways. This reviewed (1) showed the importance of phytoterpenoids to influence endoplasmic reticulum (ER) stress and homeostasis, (2) showed how regulating ER stress affect the cell survival and death, and (3) highlighted some examples of how the progression of metabolic diseases can be influenced by ER.
Due to the substantial number of terpenoids that have been identified in literature, this review gave examples of 21 terpenoids that have been documented to have an effect on the different proteins associated with ER stress, how these plant terpenoids influence ER dysfunction and metabolic diseases such as diabetes, cancer, liver, and neurological diseases and parasitic infections.